873 ISM5939, a novel, potent, orally available, selective ENPP1 inhibitor enhances the anti-tumor effects of immune checkpoint inhibitors in syngeneic murine cancer models
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1797384368320151552 |
|---|---|
| author | Man Zhang Jin Liu Celia Chen Xin Cheng Feng Ren Jianyu Wu Luoheng Qin Supriya Bavadekar Sujata Rao Alex Zhavoronkov |
| author_facet | Man Zhang Jin Liu Celia Chen Xin Cheng Feng Ren Jianyu Wu Luoheng Qin Supriya Bavadekar Sujata Rao Alex Zhavoronkov |
| author_sort | Man Zhang |
| collection | DOAJ |
| first_indexed | 2024-03-08T21:34:31Z |
| format | Article |
| id | doaj.art-afae6751e3974d32a370e307ea370e76 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-08T21:34:31Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-afae6751e3974d32a370e307ea370e762023-12-21T01:25:08ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.0873873 ISM5939, a novel, potent, orally available, selective ENPP1 inhibitor enhances the anti-tumor effects of immune checkpoint inhibitors in syngeneic murine cancer modelsMan Zhang0Jin Liu1Celia Chen2Xin Cheng3Feng Ren4Jianyu Wu5Luoheng Qin6Supriya Bavadekar7Sujata Rao8Alex Zhavoronkov9Department of Hematology, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, Heilongjiang, China1Insilico Medicine, Shanghai, China1Insilico Medicine, Shanghai, China1Insilico Medicine, Shanghai, China1Insilico Medicine, Shanghai, China1Insilico Medicine, Shanghai, China1Insilico Medicine, Shanghai, China2Insilico Medicine, New York, NY, USA2Insilico Medicine, New York, NY, USA1Insilico Medicine, Shanghai, China |
| spellingShingle | Man Zhang Jin Liu Celia Chen Xin Cheng Feng Ren Jianyu Wu Luoheng Qin Supriya Bavadekar Sujata Rao Alex Zhavoronkov 873 ISM5939, a novel, potent, orally available, selective ENPP1 inhibitor enhances the anti-tumor effects of immune checkpoint inhibitors in syngeneic murine cancer models Journal for ImmunoTherapy of Cancer |
| title | 873 ISM5939, a novel, potent, orally available, selective ENPP1 inhibitor enhances the anti-tumor effects of immune checkpoint inhibitors in syngeneic murine cancer models |
| title_full | 873 ISM5939, a novel, potent, orally available, selective ENPP1 inhibitor enhances the anti-tumor effects of immune checkpoint inhibitors in syngeneic murine cancer models |
| title_fullStr | 873 ISM5939, a novel, potent, orally available, selective ENPP1 inhibitor enhances the anti-tumor effects of immune checkpoint inhibitors in syngeneic murine cancer models |
| title_full_unstemmed | 873 ISM5939, a novel, potent, orally available, selective ENPP1 inhibitor enhances the anti-tumor effects of immune checkpoint inhibitors in syngeneic murine cancer models |
| title_short | 873 ISM5939, a novel, potent, orally available, selective ENPP1 inhibitor enhances the anti-tumor effects of immune checkpoint inhibitors in syngeneic murine cancer models |
| title_sort | 873 ism5939 a novel potent orally available selective enpp1 inhibitor enhances the anti tumor effects of immune checkpoint inhibitors in syngeneic murine cancer models |
| work_keys_str_mv | AT manzhang 873ism5939anovelpotentorallyavailableselectiveenpp1inhibitorenhancestheantitumoreffectsofimmunecheckpointinhibitorsinsyngeneicmurinecancermodels AT jinliu 873ism5939anovelpotentorallyavailableselectiveenpp1inhibitorenhancestheantitumoreffectsofimmunecheckpointinhibitorsinsyngeneicmurinecancermodels AT celiachen 873ism5939anovelpotentorallyavailableselectiveenpp1inhibitorenhancestheantitumoreffectsofimmunecheckpointinhibitorsinsyngeneicmurinecancermodels AT xincheng 873ism5939anovelpotentorallyavailableselectiveenpp1inhibitorenhancestheantitumoreffectsofimmunecheckpointinhibitorsinsyngeneicmurinecancermodels AT fengren 873ism5939anovelpotentorallyavailableselectiveenpp1inhibitorenhancestheantitumoreffectsofimmunecheckpointinhibitorsinsyngeneicmurinecancermodels AT jianyuwu 873ism5939anovelpotentorallyavailableselectiveenpp1inhibitorenhancestheantitumoreffectsofimmunecheckpointinhibitorsinsyngeneicmurinecancermodels AT luohengqin 873ism5939anovelpotentorallyavailableselectiveenpp1inhibitorenhancestheantitumoreffectsofimmunecheckpointinhibitorsinsyngeneicmurinecancermodels AT supriyabavadekar 873ism5939anovelpotentorallyavailableselectiveenpp1inhibitorenhancestheantitumoreffectsofimmunecheckpointinhibitorsinsyngeneicmurinecancermodels AT sujatarao 873ism5939anovelpotentorallyavailableselectiveenpp1inhibitorenhancestheantitumoreffectsofimmunecheckpointinhibitorsinsyngeneicmurinecancermodels AT alexzhavoronkov 873ism5939anovelpotentorallyavailableselectiveenpp1inhibitorenhancestheantitumoreffectsofimmunecheckpointinhibitorsinsyngeneicmurinecancermodels |